BPG is committed to discovery and dissemination of knowledge
Opinion Review
Copyright: ©Author(s) 2026.
World J Gastroenterol. Sep 28, 2026; 32(36): 119520
Published online Sep 28, 2026. doi: 10.3748/wjg.119520
Table 1 Evidence grading of microbiota–multi-organ axis mechanisms in aging
Mechanism
Description
Evidence level
Evidence type
Gut-brain axisMicrobiota influences BBB and microgliaStrongAnimal + human
TMAOAssociated with cardiovascular riskModerateCohort + experimental
HADHB pathwayMicrobiota-liver FAO linkLimitedAnimal
TCM-microbiotaMulti-target modulationSpeculativePreclinical
Table 2 Major microbial metabolites and their organ-level effects
Metabolite
Source
Target organ
Biological effect
SCFAsGut microbiota fermentationBrainAnti-inflammatory, BBB protection
TMAOCholine metabolismCardiovascularPro-inflammatory, atherogenic
Bile acidsLiver-microbiota interactionLiver/metabolismSignaling regulation
LPSGram-negative bacteriaSystemicInflammation activation
Tryptophan metabolitesMicrobial metabolismBrainNeurotransmitter modulation
Table 3 Key unresolved questions and recommended experimental approaches in aging research
Unresolved question
Current limitation
Recommended approach
Which microbial taxa regulate hepatic HADHBLack of causal evidenceGerm-free models + microbiota transplantation
Is TMAO causally involved in agingMostly associative dataLongitudinal human studies + intervention trials
How does microbiota affect neuroinflammationMechanisms unclearMulti-omics + BBB models
Can TCM effects be linked to microbiota causallyLimited mechanistic studiesStandardized formulations + microbiome sequencing
Are findings aging-specific or disease-drivenEvidence mainly from disease modelsDedicated aging cohorts


Write to the Help Desk